
HBS Reporting
Fauci says vast majority of vaccinated Americans should get a COVID-19 booster
-
HBS Reporting
COVID-19 pandemic could lead to HIV surge in West & Central Africa, says UNAIDS chief
Nov 5, 2021DAKAR, Nov 3 (Reuters) – West and Central Africa could see a rise in HIV infections...
-
HBS Reporting
Britain approves Merck’s COVID-19 pill in world first
Nov 5, 2021Summary * UK approval for molnupiravir comes ahead of U.S. decision * UK and NHS to...
-
HBS Reporting
Explainer: What to know about the COVID-19 vaccine for U.S. children
Nov 5, 2021NEW YORK, Nov 2 (Reuters) – A panel of advisors to the U.S. Centers for Disease...
-
HBS Reporting
Explainer: What to know about the COVID-19 vaccine for U.S. children
Nov 3, 2021NEW YORK, Nov 2 (Reuters) – A panel of advisors to the U.S. Centers for Disease...
-
HBS Reporting
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 bln
Nov 3, 2021Nov 2 (Reuters) – Pfizer Inc (PFE.N) on Tuesday said it expected 2021 sales of the...
-
HBS Reporting
U.S. CDC director backs COVID-19 vaccine for children ages 5 to 11
Nov 3, 2021Nov 2 (Reuters) – The director of the U.S. Centers for Disease Control and Prevention (CDC)...
-
HBS Reporting
China COVID-19 cases spike ahead of Communist Party conclave
Nov 3, 2021BEIJING, Nov 3 (Reuters) – China’s new locally transmitted COVID-19 cases spiked to a near three-month...
-
HBS Reporting
Zimbabwe approves Sinovac shots for older teenagers
Nov 2, 2021JOHANNESBURG, Nov 1 (Reuters) – Zimbabwe’s health ministry has approved the use of China’s Sinovac Biotech...
-
HBS Reporting
Rite Aid to make online vaccine registration portal accessible to people with disabilities
Nov 2, 2021(Reuters) – Rite Aid Corp and the U.S. Department of Justice have reached a deal to...
-
HBS Reporting
Heart attack patients with COVID-19 have lower survival rate; Israeli data supports use of Pfizer booster
Nov 2, 2021(Reuters) – The following is a summary of some recent studies on COVID-19. They include research...